» Articles » PMID: 11176486

A Validated Strategy for Side Specific Prediction of Organ Confined Prostate Cancer: a Tool to Select for Nerve Sparing Radical Prostatectomy

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2001 Feb 15
PMID 11176486
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Nerve sparing radical prostatectomy for prostate cancer should be restricted to patients who harbor tumors without capsular penetration. To our knowledge the selection criteria for nerve sparing radical prostatectomy are not clearly defined. We investigated a panel of preoperative tumor characteristics with respect to their ability to predict organ confined tumor growth for each lobe of the prostate to indicate unilateral or bilateral nerve sparing radical prostatectomy.

Materials And Methods: Nine preoperative tumor characteristics in 278 patients with clinically localized prostate cancer were included in retrospective univariate and multivariate tree structured regression analysis. The association of clinical stage, serum prostate specific antigen (PSA), PSA density, and results of transrectal ultrasound and systematic sextant biopsy, including a quantitative assessment of cancer in the biopsies with organ confined tumor growth, was statistically evaluated. Except for serum PSA and PSA density preoperative characteristics were considered separately for each prostate lobe. Multivariate analysis results were validated prospectively in 353 patients.

Results: On univariate analysis the number of positive biopsies was the most useful single parameter with a positive predictive value of 83% in 274 lobes and a negative predictive value of 55%, followed by mm. of tumor in the biopsy. Of all characteristics included in multivariate analysis only the number of biopsies with high grade cancer, the number of positive biopsies and serum PSA were independent for predicting organ confined cancer. When PSA was less than 10 ng./ml. and not more than 1 biopsy with high grade cancer was identified in a lobe, organ confined tumor growth was present in 86.1% of cases. On prospective validation the same criteria led to an 88.5% incidence of organ confined prostate cancer. Pooling the 2 most favorable groups led to 391 prostate lobes (70.8% of those investigated) with a positive predictive value of 82.1% (95% confidence interval 77.9% to 85.8%). Using the multivariate approach more prostate lobes were assigned to a favorable risk group than on univariate analysis. Clinical stage and simple Gleason grade did not contribute independent information for predicting organ confined disease.

Conclusions: Quantifying cancer and high grade cancer by systematic biopsy and serum PSA concentration are useful preoperative characteristics for predicting organ confined prostate cancer. Side specific analysis of these parameters is a flexible and reliable tool for selecting patients for nerve sparing radical prostatectomy.

Citing Articles

Predictive Factors for Extracapsular Extension of Prostate Cancer to Select the Candidates for Nerve-sparing Radical Prostatectomy.

Sekito S, Onishi T, Okamoto T, Terabe T, Kajiwara S, Shibahara T Indian J Surg Oncol. 2024; 15(2):213-217.

PMID: 38741620 PMC: 11088566. DOI: 10.1007/s13193-024-01913-1.


Prostate cancer nomograms and their application in Asian men: a review.

Panaiyadiyan S, Kumar R Prostate Int. 2024; 12(1):1-9.

PMID: 38523898 PMC: 10960090. DOI: 10.1016/j.prnil.2023.07.004.


Selection of patients for nerve sparing surgery in robot-assisted radical prostatectomy.

Vis A, van den Bergh R, van der Poel H, Mottrie A, Stricker P, Graefen M BJUI Compass. 2022; 3(1):6-18.

PMID: 35475150 PMC: 8988739. DOI: 10.1002/bco2.115.


Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers.

Meynard C, Huertas A, Dariane C, Toublanc S, Dubourg Q, Urien S Radiat Oncol. 2020; 15(1):1.

PMID: 31892338 PMC: 6938614. DOI: 10.1186/s13014-019-1449-z.


Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancer.

Chen Y, Yu W, Fan Y, Zhou L, Yang Y, Wang H Oncotarget. 2016; 8(13):22095-22103.

PMID: 27564265 PMC: 5400649. DOI: 10.18632/oncotarget.11559.